These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Greenbaum A; Martin DR; Bocklage T; Lee JH; Ness SA; Rajput A Clin Colorectal Cancer; 2019 Jun; 18(2):102-109. PubMed ID: 30935775 [TBL] [Abstract][Full Text] [Related]
3. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study. Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382 [TBL] [Abstract][Full Text] [Related]
4. Myoferlin: A Potential Marker of Response to Radiation Therapy and Survival in Locally Advanced Rectal Cancer. Fowler H; Clifford RE; Bowden D; Sutton PA; Govindarajah N; Fok M; Glenn M; Wall M; Rubbi C; Buczacki SJA; Mandal A; Francies H; Hughes J; Parsons JL; Vimalachandran D Int J Radiat Oncol Biol Phys; 2024 Nov; 120(4):1111-1123. PubMed ID: 38866213 [TBL] [Abstract][Full Text] [Related]
5. CoA synthase is in complex with p85alphaPI3K and affects PI3K signaling pathway. Breus O; Panasyuk G; Gout IT; Filonenko V; Nemazanyy I Biochem Biophys Res Commun; 2009 Aug; 385(4):581-5. PubMed ID: 19482007 [TBL] [Abstract][Full Text] [Related]
6. NPTX2 is associated with neoadjuvant therapy response in rectal cancer. Karagkounis G; Thai L; DeVecchio J; Gantt GA; Duraes L; Pai RK; Kalady MF J Surg Res; 2016 May; 202(1):112-7. PubMed ID: 27083956 [TBL] [Abstract][Full Text] [Related]
7. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling. Liu H; Zhang Z; Zhen P; Zhou M J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057 [TBL] [Abstract][Full Text] [Related]
9. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients. Troncarelli Flores BC; Souza E Silva V; Ali Abdallah E; Mello CAL; Gobo Silva ML; Gomes Mendes G; Camila Braun A; Aguiar Junior S; Thomé Domingos Chinen L Cells; 2019 Jun; 8(7):. PubMed ID: 31247977 [TBL] [Abstract][Full Text] [Related]
10. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines. Gock M; Mullins CS; Bergner C; Prall F; Ramer R; Göder A; Krämer OH; Lange F; Krause BJ; Klar E; Linnebacher M World J Gastroenterol; 2018 Nov; 24(43):4880-4892. PubMed ID: 30487698 [TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey. Langrand-Escure J; Diao P; Garcia MA; Wang G; Guy JB; Espenel S; Guillaume E; Rehailia-Blanchard A; Pigné G; de Laroche G; Kaczmarek D; Muron T; Porcheron J; Phelip JM; Vallard A; Magné N Sci Rep; 2018 Jul; 8(1):10708. PubMed ID: 30013090 [TBL] [Abstract][Full Text] [Related]
12. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer. Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma. Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399 [TBL] [Abstract][Full Text] [Related]
14. Emerging roles of non‑coding RNAs in the response of rectal cancer to radiotherapy (Review). Ha Thi HT; Duong HQ; Hong S Int J Oncol; 2021 Mar; 58(3):344-358. PubMed ID: 33650664 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies on the association of long non‑coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5‑fluorouracil in rectal cancer. Yokoyama Y; Sakatani T; Wada R; Ishino K; Kudo M; Koizumi M; Yamada T; Yoshida H; Naito Z Int J Oncol; 2019 Dec; 55(6):1361-1371. PubMed ID: 31638183 [TBL] [Abstract][Full Text] [Related]
16. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study. Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173 [TBL] [Abstract][Full Text] [Related]
17. Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity. Xu JY; Lu S; Xu XY; Hu SL; Li B; Qi RX; Chen L; Chang JY Asian Pac J Cancer Prev; 2015; 16(8):3301-6. PubMed ID: 25921135 [TBL] [Abstract][Full Text] [Related]
18. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair. Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744 [TBL] [Abstract][Full Text] [Related]